Meta description: The WARM HF trial investigates wearable device assisted remote management for atrial fibrillation with heart failure and may shape regulatory decisions. The Beijing Anzhen Hospital led study is described as Wearable Device Assisted Intervention and the record notes not yet recruiting. The official trial page is clinicaltrials.gov under NCT07411170.
Beijing Anzhen Hospital is pursuing an investigational approach that uses a wearable device to support remote management in patients with atrial fibrillation and heart failure with reduced ejection fraction. This entry documents the trial structure and signals how regulators may evaluate future device claims based on study outcomes. The information set here focuses on the registry data as published and does not provide results.
In this article you will find a concise navigation to the main topics. The sections explain what the entry signals, who is affected, how regulatory context applies, and what details are available about the trial. Readers include regulatory teams, device developers, clinicians, and payers who follow remote management technologies for chronic heart disease.